Issue 15, 2022

Metal–organic framework-based biomimetic cascade bioreactor for highly efficient treatment of hyperuricemia with low side effects

Abstract

A metal–organic framework-based biomimetic cascade bioreactor, red blood cell membrane-coated CAT@UOX@-ZIF-8, was developed for highly efficient treatment of hyperuricemia and the accompanying abnormal renal and liver function.

Graphical abstract: Metal–organic framework-based biomimetic cascade bioreactor for highly efficient treatment of hyperuricemia with low side effects

Supplementary files

Article information

Article type
Communication
Submitted
13 Jan 2022
Accepted
16 Mar 2022
First published
17 Mar 2022

New J. Chem., 2022,46, 6852-6855

Metal–organic framework-based biomimetic cascade bioreactor for highly efficient treatment of hyperuricemia with low side effects

F. Li, Y. Zhang, F. Wang, J. Chen, B. Wang, N. Li, X. Lin and J. Zhuang, New J. Chem., 2022, 46, 6852 DOI: 10.1039/D2NJ00208F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements